SCHEMBL7103494

SCHEMBL7103494

Cc1c(N)ccc2sc3ccccc3c12.Cc1c([N+](=O)[O-])ccc2sc3ccccc3c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
TSHR P16473 3/20 0.38
MAPT P10636 6/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SLC9A1 P19634 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CTSB P07858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5120287 0.92 TDP1 (0.46) TDP1TSHRMAPTRAB9AHPGD
SCHEMBL5120258 0.84 GPR3 (0.46) TDP1TSHRMAPTRAB9AHPGD
SCHEMBL17952462 0.77 MAPT (0.42) TDP1MAPTRAB9AHPGDNPC1
SCHEMBL31677913 0.76 LMNA (0.43) TDP1TSHRMAPTHPGDCYP3A4
SCHEMBL16919342 0.75 CTSB (0.40) TDP1TSHRMAPTRAB9AHPGD
SCHEMBL3293386 0.74 TDP1 (0.53) TDP1MAPTCYP3A4SLC9A1ALDH1A1
SCHEMBL31478092 0.74 TDP1 (0.53) TDP1MAPTCYP3A4SLC9A1ALDH1A1
SCHEMBL16919393 0.71 KMT2A (0.43) TDP1MAPTRAB9AHPGDNPC1
SCHEMBL1683191 0.71 TSHR (0.57) TDP1TSHRMAPTCYP3A4SMN1; SMN2
SCHEMBL16218709 0.69 TDP1 (0.47) TDP1MAPTRAB9ANPC1SLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278739-A1 AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR AstraZeneca AB (SE) 2003-01-29 EP disclosed
WO-2001085714-A1 AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR ASTRAZENECA AB (SE) 2001-11-15 WO disclosed